These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17473182)

  • 1. Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer.
    Kawamoto K; Okino ST; Place RF; Urakami S; Hirata H; Kikuno N; Kawakami T; Tanaka Y; Pookot D; Chen Z; Majid S; Enokida H; Nakagawa M; Dahiya R
    Clin Cancer Res; 2007 May; 13(9):2541-8. PubMed ID: 17473182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines.
    Lambrot R; Kimmins S
    Int J Androl; 2011 Apr; 34(2):110-23. PubMed ID: 20497257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA methylation and histone modification relate to RASSF1A gene deletion in laryngeal carcinoma tissues].
    Yang J; Ji WY; Qu YR; He LX; Zhao XD; Jin MZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):308-12. PubMed ID: 21624251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
    Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
    Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments.
    Tabolacci E; Pietrobono R; Moscato U; Oostra BA; Chiurazzi P; Neri G
    Eur J Hum Genet; 2005 May; 13(5):641-8. PubMed ID: 15741991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
    Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
    Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression.
    Yan C; Boyd DD
    Mol Cell Biol; 2006 Sep; 26(17):6357-71. PubMed ID: 16914722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.
    Nguyen CT; Weisenberger DJ; Velicescu M; Gonzales FA; Lin JC; Liang G; Jones PA
    Cancer Res; 2002 Nov; 62(22):6456-61. PubMed ID: 12438235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer.
    Beyer S; Zhu J; Mayr D; Kuhn C; Schulze S; Hofmann S; Dannecker C; Jeschke U; Kost BP
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28241481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.
    Kikuno N; Shiina H; Urakami S; Kawamoto K; Hirata H; Tanaka Y; Majid S; Igawa M; Dahiya R
    Int J Cancer; 2008 Aug; 123(3):552-60. PubMed ID: 18431742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer.
    Henrique R; Oliveira AI; Costa VL; Baptista T; Martins AT; Morais A; Oliveira J; Jerónimo C
    BMC Genomics; 2013 Dec; 14():898. PubMed ID: 24344919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.
    Shinojima T; Yu Q; Huang SK; Li M; Mizuno R; Liu ET; Hoon DS; Lessard L
    Epigenetics; 2012 Nov; 7(11):1279-89. PubMed ID: 23023649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter.
    Strunnikova M; Schagdarsurengin U; Kehlen A; Garbe JC; Stampfer MR; Dammann R
    Mol Cell Biol; 2005 May; 25(10):3923-33. PubMed ID: 15870267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Cancer Invest; 2010 May; 28(4):331-9. PubMed ID: 19857042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
    J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells.
    Xiang N; Zhao R; Song G; Zhong W
    Carcinogenesis; 2008 Nov; 29(11):2175-81. PubMed ID: 18676679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of CIITA expression in human T-cells.
    van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
    Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.